Biogen Idec gains commercial rights of Tysabri from Elan

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis

Biogen Idec gains commercial rights of Tysabri from Elan

Postby MSUK » Thu Apr 04, 2013 1:27 am

Biogen Idec gains commercial rights of Tysabri from Elan Corporation

Biogen Idec has completed its purchase of Elan Corporation’s interest in Tysabri (natalizumab) and has gained full strategic, commercial and decision-making rights of Tysabri. The transaction was originally announced on February 6, 2013....................Read More - http://www.ms-uk.org/index.cfm/tysabri
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2157
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Re: Biogen Idec gains commercial rights of Tysabri from Elan

Postby HarryZ » Thu Apr 04, 2013 5:37 am

squiffy2 wrote:Biogen Idec gains commercial rights of Tysabri from Elan Corporation

Biogen Idec has completed its purchase of Elan Corporation’s interest in Tysabri (natalizumab) and has gained full strategic, commercial and decision-making rights of Tysabri. The transaction was originally announced on February 6, 2013....................Read More - http://www.ms-uk.org/index.cfm/tysabri


Makes you wonder if Elan knows something about Tysabri that we don't and got out after making as much money as they could.
User avatar
HarryZ
Family Elder
 
Posts: 2557
Joined: Tue May 25, 2004 3:00 pm
Location: London, ON, Canada


Return to Tysabri (Antegren or Natalizumab)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service